Items where Author is "Aboagye, R. G."

Article

(2025) Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. pp. 36-51. ISSN 14733099 (ISSN)

(2024) Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet. pp. 2341-2370. ISSN 01406736 (ISSN)

(2024) Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2204-2256. ISSN 0140-6736

(2024) Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 1989-2056. ISSN 0140-6736

(2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2162-2203. ISSN 0140-6736

(2024) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2100-2132. ISSN 0140-6736

(2024) Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet. pp. 1199-1226. ISSN 01406736 (ISSN)

(2024) Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020. Eye. pp. 2083-2101. ISSN 0950-222X

(2024) Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020. Eye. pp. 2156-2172. ISSN 0950-222X

(2024) Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020. Eye. pp. 2036-2046. ISSN 0950-222X

(2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2133-2161. ISSN 0140-6736

(2024) Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infectious Diseases. pp. 698-725. ISSN 1473-3099

(2024) Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurology. pp. 344-381. ISSN 1474-4422

(2024) Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology. pp. 973-1003. ISSN 14744422 (ISSN)

(2024) Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet. pp. 1955-1988. ISSN 0140-6736

(2024) National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050. The Lancet. pp. 2278-2298. ISSN 01406736 (ISSN)

(2024) The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. pp. 2314-2340. ISSN 01406736 (ISSN)

(2023) Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026. Lancet Global Health. E385-E413. ISSN 2214-109X

(2023) Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Allergy: European Journal of Allergy and Clinical Immunology. pp. 2232-2254. ISSN 01054538 (ISSN)

(2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 203-234. ISSN 0140-6736

(2023) Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurology. pp. 685-711. ISSN 1474-4422

(2023) Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. Eclinicalmedicine. p. 23.

(2023) Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematology. E585-E599. ISSN 2352-3026

(2023) Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet Haematology. e713-e734. ISSN 2352-3026

(2022) Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019. Lancet Public Health. E657-E669. ISSN 2468-2667

(2022) Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infectious Diseases. pp. 1626-1647. ISSN 1473-3099

(2022) Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 2221-2248. ISSN 0140-6736

(2022) The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 563-591. ISSN 0140-6736